The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Can telemedicine and exercise apps improve the health of people with type 2 diabetes and coronary heart disease? A large ...

Nerve damage: Diabetes can damage nerves responsible for the heart and blood vessels, affecting the heart's rhythm and the ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

People with type 2 diabetes who were given ketones before exercise had increased cardiac output, stroke volume, and ...

Discover how regular exercise can strengthen your heart, regulate blood sugar and lower heart disease risk for those with ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

A new study published in the Journal of the Society for Cardiovascular Angiography & Interventions has revealed a lower risk ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...